I found the following article about lutetium 177 and its not been made available. Why is it not cost-effective? NICE done the same with oplaparib in England and Wales. I couldn't find anything about it in Scotland as yet though
https://www.prostate-cancer-research.org.uk/nice-consults-on-decision-to-block-pluvicto/